|

GC203 TIL Clinical Trials

2 actively recruiting trials

▲ +1 trial since August 2026

Pipeline

Early 1: 1Phase 1: 1

Top Sponsors

  • Shanghai Juncell Therapeutics2

Indications

  • Cancer2
  • Pancratic Ductal Adenocarcinoma1
  • Solid Tumors, Adult1
  • Pancreatic Cancer1
  • Treatment Side Effects1

Other2 trials

A Study of GC203 TIL in Advanced Solid Tumors (NF)
Phase 1
A Study of GC203 TIL in PDCA (RJ)
Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.